Clinical Trial Update: Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of losmapimod in chronic obstructive pulmonary disease patients stratified by fibrinogen has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Losmapimod (losmapimod)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED